GDF15 and metabolic dysfunction-associated steatohepatitis: For this purpose, liver sections from a subset of 15 patients with MASLD were used for the analysis of GDF15 gene expression levels, which resulted to be higher in MASH (n = 9) than in Not-MASH (n = 6) livers (Figure 3A).